BUBS Australia Ltd (ASX: BUB) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
BUBS Australia Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
BUBS Australia Ltd (ASX: BUB)
Latest News
Broker Notes
How high could Bubs Australia shares go, according to Bell Potter?
Consumer Staples & Discretionary Shares
Bubs shares just rocketed 40%. Here's the news investors were waiting for
Consumer Staples & Discretionary Shares
This ASX share jumped 7% before a trading halt. What's going on?
Broker Notes
How high do brokers think Bubs Australia shares will go?
Cheap Shares
2 ASX shares tipped to grow 50% or more in the next 12 months
Broker Notes
Top broker says this small-cap ASX stock could rise almost 50%
Consumer Staples & Discretionary Shares
This ASX small-cap stock is sliding after a tough FY26 update
Growth Shares
2 ASX shares tipped to grow at least 50% in the next 12 months
Broker Notes
Buy, hold, or sell? Bubs, Soul Patts, and Endeavour shares
ASX Share Market News
This small-cap ASX share could rise 60%
Consumer Staples & Discretionary Shares
This penny stock could deliver 50% upside, Shaw and Partners says
Broker Notes
Buy, hold, sell: Bubs, Origin Energy, 4D Medical shares
Frequently Asked Questions
-
No, Bubs Australia does not pay dividends at this stage.
-
Bubs Australia Ltd listed on the ASX on 5 October 1993.
BUB ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About BUBS Australia Ltd
Bubs Australia Ltd (ASX: BUB) is a producer of infant nutrition products. The company offers a range of infant formulas including organic grass-fed cows' milk and goat milk products, as well as organic baby food, nutritional supplements, and cereals.
Bubs Australia is also a major Australian supplier of goat milk and goat milk powder for both the infant and adult markets.
The company's products are widely sold in supermarkets and pharmacies in Australia and exported to China, Southeast Asia, and the Middle East.
BUB Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 20 Oct 2026 | $0.10 | $0.00 | 0.00% | 676,839 | $0.10 | $0.10 | $0.09 |
| 19 Oct 2026 | $0.10 | $0.00 | 0.00% | 413,605 | $0.10 | $0.10 | $0.10 |
| 16 Oct 2026 | $0.10 | $0.00 | 0.00% | 713,929 | $0.10 | $0.10 | $0.09 |
| 15 Oct 2026 | $0.10 | $-0.01 | -10.00% | 1,829,474 | $0.10 | $0.10 | $0.09 |
| 14 Oct 2026 | $0.10 | $0.00 | 0.00% | 886,538 | $0.10 | $0.10 | $0.10 |
| 13 Oct 2026 | $0.10 | $0.00 | 0.00% | 2,137,623 | $0.10 | $0.10 | $0.10 |
| 12 Oct 2026 | $0.10 | $-0.01 | -9.52% | 1,646,725 | $0.11 | $0.11 | $0.10 |
| 09 Oct 2026 | $0.11 | $0.01 | 10.10% | 1,211,160 | $0.10 | $0.11 | $0.10 |
| 08 Oct 2026 | $0.10 | $0.00 | 0.00% | 2,107,561 | $0.10 | $0.10 | $0.10 |
| 07 Oct 2026 | $0.10 | $0.00 | 0.00% | 655,968 | $0.10 | $0.10 | $0.10 |
| 06 Oct 2026 | $0.10 | $0.00 | 0.00% | 2,746,690 | $0.10 | $0.11 | $0.10 |
| 05 Oct 2026 | $0.10 | $0.00 | 0.00% | 6,817,812 | $0.10 | $0.10 | $0.10 |
| 02 Oct 2026 | $0.10 | $0.00 | 0.00% | 1,653,368 | $0.10 | $0.10 | $0.10 |
| 01 Oct 2026 | $0.10 | $0.00 | 0.00% | 1,824,981 | $0.10 | $0.10 | $0.10 |
| 30 Sep 2026 | $0.10 | $0.00 | 0.00% | 1,833,884 | $0.10 | $0.11 | $0.10 |
| 29 Sep 2026 | $0.10 | $0.00 | 0.00% | 1,908,313 | $0.10 | $0.11 | $0.10 |
| 28 Sep 2026 | $0.10 | $-0.01 | -9.52% | 2,950,079 | $0.11 | $0.11 | $0.10 |
| 25 Sep 2026 | $0.11 | $0.00 | 0.00% | 50,679 | $0.10 | $0.11 | $0.10 |
| 24 Sep 2026 | $0.10 | $0.00 | 0.00% | 1,802,059 | $0.10 | $0.11 | $0.10 |
| 23 Sep 2026 | $0.11 | $0.00 | 0.00% | 1,225,396 | $0.11 | $0.11 | $0.10 |
| 22 Sep 2026 | $0.11 | $-0.01 | -8.70% | 2,765,314 | $0.12 | $0.12 | $0.11 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 15 Sep 2026 | Paul Jensen | Buy | 500,000 | $55,000 |
On-market trade.
|
| 10 Sep 2026 | Lori Marcus | Buy | 900,000 | $117,000 |
On-market trade.
|
| 03 Sep 2026 | Lori Marcus | Buy | 100,000 | $9,500 |
On-market trade.
|
| 02 Sep 2026 | Pascal Petrini | Buy | 800,000 | $70,400 |
On-market trade.
|
| 01 Sep 2026 | Paul Jensen | Buy | 1,500,000 | $130,500 |
On-market trade.
|
| 17 Mar 2026 | Paul Jensen | Buy | 250,000 | $28,750 |
On-market trade.
|
| 03 Mar 2026 | Paul Jensen | Buy | 75,156 | $9,018 |
On-market trade.
|
| 02 Mar 2026 | Paul Jensen | Buy | 674,844 | $80,981 |
On-market trade.
|
| 21 Nov 2025 | Joe Coote | Issued | 7,132,645 | $998,570 |
Issue of securities. 7,132,645 Performance Rights
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Paul David Kristian Jensen | Non-Executive DirectorNon-Executive Chairman | Mar 2023 |
Mr Jensen has more than 20 years' board experience across ASX-listed, public and private organisations. He has expertise in corporate governance, finance, capital management and corporate strategy. His experience spans consumer goods, financial services, government, philanthropy and Indigenous affairs. Prior to his non-executive career, Paul held senior executive positions in banking and investment management. He worked internationally with Lloyds Banking Group in New Zealand, the United Kingdom and Australia, and subsequently served as Managing Director of two ASX-listed investment companies.
|
| Mr Steve Lin | Non-Executive Director | Apr 2019 |
Mr Lin has more than 30 years of investment, operations and management experience across Asia and the United States. He is Managing Partner of C2 Capital, a private equity investment firm focused on consumer brands and growth opportunities in global markets. He has conducted business in China for more than 30 years and brings experience working with companies, investors and institutions across the region. Prior to joining C2 Capital, he held roles with Morgan Stanley, Goldman Sachs, GMAC Commercial Holding Corp (subsequently Capmark Financial Group) and Laureate Education across New York, Hong Kong and Tokyo.
|
| Mr Joe Coote | Chief Executive OfficerManaging Director | Jul 2025 |
Mr Coote has more than 20 years of global leadership experience across the FMCG, dairy and infant nutrition sectors, with expertise in commercial operations, supply chain management, international market development and business transformation. He spent 12 years with Fonterra in senior leadership roles across New Zealand, Asia and the United States, culminating in his appointment as President, Fonterra Americas. He has experience leading growth strategies across international markets.
|
| Mr Pascal De Petrini | Non-Executive Director | Apr 2026 |
Mr Petrini has more than 30 years of international leadership experience across the dairy, infant nutrition and consumer goods sectors. He has expertise in infant formula and dairy, together with a proven track record of building brands, driving growth and delivering operational excellence across multiple international markets. His experience spans end-to-end supply chain management, regulatory affairs, commercial strategy and organisational transformation. He is the chairperson of the Risk Committee.
|
| Ms Lori Tauber Marcus | Non-Executive Director | May 2026 |
Mr Marcus has more than 30 years of senior marketing and consumer brand experience across FMCG, retail, consumer health, digital commerce and high-growth consumer businesses. Her career included 24 years with PepsiCo. She has expertise in brand strategy, consumer engagement, digital marketing, innovation and commercial growth. Her experience consists of building consumer brands and driving business transformation across global markets.
|
| Mr Peter Cope | General CounselCompany Secretary | Jan 2025 |
-
|
| Richard Paine | COO |
-
|
|
| Peter Cope | General CounselCompany Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| C2 Capital Global Export To China Fund | 76,288,510 | 8.53% |
| Ataturk Investments Pty Ltd | 57,586,374 | 6.44% |
| J P Morgan Nominees Australia Pty Limited | 21,950,137 | 2.45% |
| Citicorp Nominees Pty Limited | 16,029,491 | 1.79% |
| Keong Lim Pty Limited <Sk Lim Family A/C> | 9,724,000 | 1.09% |
| Mr Benjamin Paul Landon | 8,001,271 | 0.89% |
| BNP Paribas Nominees Pty Ltd <IB AU Noms RetailClient> | 7,250,796 | 0.81% |
| Mr Jianlin Zhou | 7,008,000 | 0.78% |
| HSBC Custody Nominees (Australia) Limited | 7,007,040 | 0.78% |
| Code Nominees Pty Ltd <Retail A/C> | 6,813,332 | 0.76% |
| Velrosso Pty Ltd <Harvey 1995 Disc A/C> | 6,700,000 | 0.75% |
| Lavya Pty Ltd <Lavya Family A/C> | 6,300,905 | 0.70% |
| Finclear Services Pty Ltd <Superhero Securities A/C> | 5,732,879 | 0.64% |
| Boom Securities (Hk) Limited <Clients Account> | 5,219,561 | 0.58% |
| Costa Asset Management Pty Ltd <Costa Asset Mgmt Unit A/C> | 5,200,000 | 0.58% |
| BNP Paribas Nominees Pty Ltd <Clearstream> | 4,738,012 | 0.53% |
| Stable Charter Limited | 4,615,385 | 0.52% |
| Mr Xin Fan | 4,500,000 | 0.50% |
| Ms Liying Wang | 4,200,000 | 0.47% |
| Mr Gilbert Peter James Battistella | 4,050,089 | 0.45% |